{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T06:40:10Z","timestamp":1736664010570,"version":"3.32.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,11]]},"DOI":"10.7759\/cureus.77302","type":"journal-article","created":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T06:17:10Z","timestamp":1736662630000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessing the Knowledge, Attitude, and Practice of Healthcare Workers on the Herpes Zoster Vaccine in Saudi Arabia: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Nouran M","family":"Moustafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Alsaif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Alsaeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alreem","family":"Alanezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Algarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Alkathery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001582","article-title":"Evaluating physician attitudes and practices regarding herpes zoster vaccination","volume":"37","author":"Tsui E","year":"2018","unstructured":"Tsui E, Gillespie C, Perskin M, Zabar S, Wu M, Cohen EJ. Evaluating physician attitudes and practices regarding herpes zoster vaccination. Cornea. 2018, 37:947-51. 10.1097\/ICO.0000000000001582","journal-title":"Cornea"},{"key":"ref2","article-title":"Varicella-Zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies","volume":"41","author":"2. Freer G","year":"2018","unstructured":"2. Freer G, Pistello M. Varicella-Zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies. New Microbiol. 2018, 41:95-105.","journal-title":"New Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1086\/644646","article-title":"Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals","volume":"200","author":"Okamoto S","year":"2009","unstructured":"Okamoto S, Hata A, Sadaoka K, Yamanishi K, Mori Y. Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis. 2009, 200:1606-10. 10.1086\/644646","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_1021_16","article-title":"Epidemiology, treatment and prevention of herpes zoster: a comprehensive review","volume":"84","author":"Koshy E","year":"2018","unstructured":"Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review. Indian J Dermatol Venereol Leprol. 2018, 84:251-62. 10.4103\/ijdvl.IJDVL_1021_16","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.11.012","article-title":"Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older","volume":"27","author":"Stein AN","year":"2009","unstructured":"Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine. 2009, 27:520-9. 10.1016\/j.vaccine.2008.11.012","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.043","article-title":"The burden of skin disease in the United States","volume":"76","author":"Lim HW","year":"2017","unstructured":"Lim HW, Collins SA, Resneck JS Jr, et al.. The burden of skin disease in the United States. J Am Acad Dermatol. 2017, 76:958-972.e2. 10.1016\/j.jaad.2016.12.043","journal-title":"J Am Acad Dermatol"},{"key":"ref7","article-title":"Management strategies for herpes zoster and postherpetic neuralgia","volume":"107","author":"Galluzzi KE","year":"2007","unstructured":"Galluzzi KE. Management strategies for herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc. 2007, 107:S8-S13.","journal-title":"J Am Osteopath Assoc"},{"key":"ref8","article-title":"Herpes zoster and postherpetic neuralgia: prevention and management","volume":"83","author":"Fashner J","year":"2011","unstructured":"Fashner J, Bell AL. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Phys. 2011, 83:1432-7.","journal-title":"Am Fam Phys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44 Suppl 1","author":"Dworkin RH","year":"2007","unstructured":"Dworkin RH, Johnson RW, Breuer J, et al.. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007, 44 Suppl 1:S1-26. 10.1086\/510206","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2018.10.010","article-title":"Vaccination in the elderly: the challenge of immune changes with aging","volume":"40","author":"Ciabattini A","year":"2018","unstructured":"Ciabattini A, Nardini C, Santoro F, Garagnani P, Franceschi C, Medaglini D. Vaccination in the elderly: the challenge of immune changes with aging. Semin Immunol. 2018, 40:83-94. 10.1016\/j.smim.2018.10.010","journal-title":"Semin Immunol"},{"key":"ref11","unstructured":"Shingles (herpes zoster) | CDC. Accessed. February 10, 2022: https:\/\/www.cdc.gov\/shingles\/index.html."},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-013-0088-1","article-title":"Shingles (herpes zoster) vaccine (Zostavax\u00ae): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged \u226550 years","volume":"73","author":"Keating G","year":"2013","unstructured":"Keating G. Shingles (herpes zoster) vaccine (Zostavax\u00ae): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged \u226550 years. Drugs. 2013, 73:1227-44.","journal-title":"Drugs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0088-1","article-title":"Shingles (herpes zoster) vaccine (zostavax(\u00ae)): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged \u226550 years","volume":"73","author":"Keating GM","year":"2013","unstructured":"Keating GM. Shingles (herpes zoster) vaccine (zostavax(\u00ae)): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged \u226550 years. Drugs. 2013, 73:1227-44. 10.1007\/s40265-013-0088-1","journal-title":"Drugs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00483-1","article-title":"Herpes zoster presentation, management, and prevention: a modern case-based review","volume":"21","author":"Rosamilia LL","year":"2020","unstructured":"Rosamilia LL. Herpes zoster presentation, management, and prevention: a modern case-based review. Am J Clin Dermatol. 2020, 21:97-107. 10.1007\/s40257-019-00483-1","journal-title":"Am J Clin Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07721-z","article-title":"Survey of physician practices, attitudes, and knowledge regarding recombinant zoster vaccine","volume":"38","author":"Hurley LP","year":"2023","unstructured":"Hurley LP, O'Leary ST, Dooling K, et al.. Survey of physician practices, attitudes, and knowledge regarding recombinant zoster vaccine. J Gen Intern Med. 2023, 38:986-93. 10.1007\/s11606-022-07721-z","journal-title":"J Gen Intern Med"},{"key":"ref16","unstructured":"FDA OKs Shingrix for Immunocompromised adults 18 years and older. (2021). https.\/\/www.drugtopics.com\/view\/fda-oks-shingrix-for-immunocompromised-adults-18-years-and-older."},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022","volume":"71","author":"Anderson TC","year":"2022","unstructured":"Anderson TC, Masters NB, Guo A, et al.. Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:80-4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref18","unstructured":"Shingles (herpes zoster) vaccination information for healthcare providers. (2022). Accessed. December 18, 2022: https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/hcp\/index.html."},{"key":"ref19","article-title":"Shingrix for herpes zoster: a review","volume":"24","author":"Shah RA","year":"2019","unstructured":"Shah RA, Limmer AL, Nwannunu CE, Patel RR, Mui UN, Tyring SK. Shingrix for herpes zoster: a review. Skin Ther Lett. 2019, 24:5-7.","journal-title":"Skin Ther Lett"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001718","article-title":"Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition","volume":"161","author":"Harvey M","year":"2020","unstructured":"Harvey M, Prosser LA, Rose AM, Ortega-Sanchez IR, Harpaz R. Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition. Pain. 2020, 161:361-8. 10.1097\/j.pain.0000000000001718","journal-title":"Pain"},{"key":"ref21","unstructured":"Centers for Disease Control and Prevention (CDC). Vaccination coverage among adults in the United States, national health interview survey. (2017). Accessed. January 2022: https:\/\/link.springer.com\/referenceworkentry\/10.1007\/978-3-319-32010-6_258."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of vaccination coverage among adult populations -United States, 2018","volume":"70","author":"Lu PJ","year":"2021","unstructured":"Lu PJ, Hung MC, Srivastav A, et al.. Surveillance of vaccination coverage among adult populations -United States, 2018. MMWR Surveill Summ. 2021, 70:1-26. 10.15585\/mmwr.ss7003a1","journal-title":"MMWR Surveill Summ"},{"key":"ref23","article-title":"Health care professionals\u2019 advice can increase COVID-19 vaccination","volume":"327","author":"Kuehn B","year":"2022","unstructured":"Kuehn B. Health care professionals\u2019 advice can increase COVID-19 vaccination. JAMA. 2022, 327:518.","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2018.09.024","article-title":"U.S. clinicians\u2019 and pharmacists\u2019 reported barriers to implementation of the standards for adult immunization practice","volume":"36","author":"Srivastav A","year":"2018","unstructured":"Srivastav A, Black CL, Lutz CS, et al.. U.S. clinicians\u2019 and pharmacists\u2019 reported barriers to implementation of the standards for adult immunization practice. Vaccine. 2018, 36:6772-81.","journal-title":"Vaccine"},{"key":"ref25","unstructured":"An introduction to OpenEpi. (2014). http.\/\/www.testopenepi.com\/Documentation\/OpenEpiIntro.htm."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020148","article-title":"Healthcare workers\u2019 knowledge, attitudes, and practices about vaccinations: a cross-sectional study in Italy","volume":"8","author":"Pelullo CP","year":"2020","unstructured":"Pelullo CP, Della Polla G, Napolitano F, Di Giuseppe G, Angelillo IF. Healthcare workers\u2019 knowledge, attitudes, and practices about vaccinations: a cross-sectional study in Italy. Vaccines (Basel). 2020, 8:10.3390\/vaccines8020148","journal-title":"Vaccines (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.15326\/jcopdf.2022.0322","article-title":"Health care professionals\u2019 herpes zoster awareness and vaccine recommendations for patients with COPD","volume":"9","author":"Yawn BP","year":"2022","unstructured":"Yawn BP, Loskutova NY, Merrill DD, et al.. Health care professionals\u2019 herpes zoster awareness and vaccine recommendations for patients with COPD. Chronic Obstr Pulm Dis. 2022, 9:562-75. 10.15326\/jcopdf.2022.0322","journal-title":"Chronic Obstr Pulm Dis"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1186\/s12909-023-04590-w","article-title":"Physicians\u2019 knowledge, attitude and perceptions towards vaccine-hesitant parents: a cross-sectional study","volume":"23","author":"Albaker AR","year":"2023","unstructured":"Albaker AR, Azer SA, AlKhorayef M, et al.. Physicians\u2019 knowledge, attitude and perceptions towards vaccine-hesitant parents: a cross-sectional study. BMC Medical Education. 2023, 23:637.","journal-title":"BMC Medical Education"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2022.04.097","article-title":"Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries","volume":"40","author":"Leigh JP","year":"2022","unstructured":"Leigh JP, Moss SJ, White TM, et al.. Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries. Vaccine. 2022, 40:4081-9.","journal-title":"Vaccine"},{"key":"ref30","article-title":"Recommendations and guidance for herpes zoster vaccination for adults in Taiwan","author":"Lin KY","year":"2024","unstructured":"Lin KY, Wang CH, Su LY, et al.. Recommendations and guidance for herpes zoster vaccination for adults in Taiwan. J Microbiol Immunol Infect. 2024,","journal-title":"J Microbiol Immunol Infect"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2023.0284","article-title":"Knowledge, attitudes, and practices regarding herpes zoster vaccination among specialists","volume":"27","author":"Singer D","year":"2024","unstructured":"Singer D, Sweeney C, Stempniewicz N, Reynolds M, Garbinsky D, Poston S. Knowledge, attitudes, and practices regarding herpes zoster vaccination among specialists. Popul Health Manag. 2024, 27:231-40. 10.1089\/pop.2023.0284","journal-title":"Popul Health Manag"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e371","article-title":"Effective vaccination and education strategies for emerging infectious diseases such as COVID-19","volume":"38","author":"Wie SH","year":"2023","unstructured":"Wie SH, Jung J, Kim WJ. Effective vaccination and education strategies for emerging infectious diseases such as COVID-19. J Korean Med Sci. 2023, 38:e371. 10.3346\/jkms.2023.38.e371","journal-title":"J Korean Med Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192113872","article-title":"Understanding primary care physician vaccination behaviour: a systematic review","volume":"19","author":"Prieto-Campo \u00c1","year":"2022","unstructured":"Prieto-Campo \u00c1, Garc\u00eda-\u00c1lvarez RM, L\u00f3pez-Dur\u00e1n A, Roque F, Herdeiro MT, Figueiras A, Zapata-Cachafeiro M. Understanding primary care physician vaccination behaviour: a systematic review. Int J Environ Res Public Health. 2022, 19:10.3390\/ijerph192113872","journal-title":"Int J Environ Res Public Health"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060948","article-title":"COVID-19 vaccination hesitancy among healthcare workers\u2014a review","volume":"10","author":"Peterson CJ","year":"2022","unstructured":"Peterson CJ, Lee B, Nugent K. COVID-19 vaccination hesitancy among healthcare workers\u2014a review. Vaccines (Basel). 2022, 10:10.3390\/vaccines10060948","journal-title":"Vaccines (Basel)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1621147","article-title":"Challenges facing vaccinators in the 21(st) century: results from a focus group qualitative study","volume":"15","author":"Wiot F","year":"2019","unstructured":"Wiot F, Shirley J, Prugnola A, Di Pasquale A, Philip R. Challenges facing vaccinators in the 21(st) century: results from a focus group qualitative study. Hum Vaccin Immunother. 2019, 15:2806-15. 10.1080\/21645515.2019.1621147","journal-title":"Hum Vaccin Immunother"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9070713","article-title":"Healthcare providers\u2019 vaccine perceptions, hesitancy, and recommendation to patients: a systematic review","volume":"9","author":"Lin C","year":"2021","unstructured":"Lin C, Mullen J, Smith D, Kotarba M, Kaplan SJ, Tu P. Healthcare providers\u2019 vaccine perceptions, hesitancy, and recommendation to patients: a systematic review. Vaccines (Basel). 2021, 9:10.3390\/vaccines9070713","journal-title":"Vaccines (Basel)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckab209","article-title":"Health care provider trust in vaccination: a systematic review and qualitative meta-synthesis","volume":"32","author":"Ahmad M","year":"2022","unstructured":"Ahmad M, Akande A, Majid U. Health care provider trust in vaccination: a systematic review and qualitative meta-synthesis. Eur J Public Health. 2022, 32:207-13. 10.1093\/eurpub\/ckab209","journal-title":"Eur J Public Health"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of from GSK for the development of the study materials, the the advisory committee on immunization practices for use conduct of the study, and analysis and interpretation of the of herpes zoster vaccines","volume":"67","author":"Dooling KL","year":"2018","unstructured":"Dooling KL, Guo A, Patel M, et al.. Recommendations of from GSK for the development of the study materials, the the advisory committee on immunization practices for use conduct of the study, and analysis and interpretation of the of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018, 67:103-8.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14683","article-title":"Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients","volume":"20","author":"George S","year":"2024","unstructured":"George S, Regan J, Awan A, et al.. Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients. Hum Vaccin Immunother. 2024, 20:2317595. 10.1111\/ajt.14683","journal-title":"Hum Vaccin Immunother"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.3389\/phrs.2024.1606679","article-title":"Unraveling herpes zoster vaccine hesitancy, acceptance, and its predictors: insights from a scoping review","volume":"45","author":"Wang X","year":"2024","unstructured":"Wang X, Shang S, Zhang E, et al.. Unraveling herpes zoster vaccine hesitancy, acceptance, and its predictors: insights from a scoping review. Public Health Rev. 2024, 45:1606679.","journal-title":"Public Health Rev"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s40794-023-00202-z","article-title":"Herpes zoster vaccine awareness and acceptance among adults in Saudi Arabia: a survey-based cross-sectional study","volume":"9","author":"AlMuammar S","year":"2023","unstructured":"AlMuammar S, Albogmi A, Alzahrani M, Alsharef F, Aljohani R, Aljilani T. Herpes zoster vaccine awareness and acceptance among adults in Saudi Arabia: a survey-based cross-sectional study. Trop Dis Travel Med Vaccines. 2023, 9:17. 10.1186\/s40794-023-00202-z","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47136","article-title":"Analyzing COVID-19 vaccination side effects among the adult population in Jeddah, Saudi Arabia","volume":"15","author":"Alamri T","year":"2023","unstructured":"Alamri T, Anwer F, Butt NS, et al.. Analyzing COVID-19 vaccination side effects among the adult population in Jeddah, Saudi Arabia. Cureus. 2023, 15:e47136. 10.7759\/cureus.47136","journal-title":"Cureus"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01076-w","article-title":"Safety profile of the adjuvanted recombinant zoster vaccine in immunocompromised populations: an overview of six trials","volume":"44","author":"L\u00f3pez-Fauqued M","year":"2021","unstructured":"L\u00f3pez-Fauqued M, Co-van der Mee M, Bastidas A, et al.. Safety profile of the adjuvanted recombinant zoster vaccine in immunocompromised populations: an overview of six trials. Drug Saf. 2021, 44:811-23. 10.1007\/s40264-021-01076-w","journal-title":"Drug Saf"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2263979","article-title":"Effectiveness and safety of recombinant zoster vaccine: a review of real-world evidence","volume":"19","author":"Parikh R","year":"2023","unstructured":"Parikh R, Singer D, Chmielewski-Yee E, Dessart C. Effectiveness and safety of recombinant zoster vaccine: a review of real-world evidence. Hum Vaccin Immunother. 2023, 19:2263979. 10.1080\/21645515.2023.2263979","journal-title":"Hum Vaccin Immunother"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1926184","article-title":"Improving the availability of vaccines in primary healthcare facilities in South Africa: is the time right for a system redesign process?","volume":"18","author":"Iwu-Jaja CJ","year":"2022","unstructured":"Iwu-Jaja CJ, Jordan P, Ngcobo N, Jaca A, Iwu CD, Mulenga M, Wiysonge C. Improving the availability of vaccines in primary healthcare facilities in South Africa: is the time right for a system redesign process?. Hum Vaccin Immunother. 2022, 18:1926184. 10.1080\/21645515.2021.1926184","journal-title":"Hum Vaccin Immunother"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.03.024","article-title":"Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: data from active surveillance program. Puglia (Italy), 2021-23","volume":"42","author":"Stefanizzi P","year":"2024","unstructured":"Stefanizzi P, Moscara L, Palmieri C, et al.. Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: data from active surveillance program. Puglia (Italy), 2021-23. Vaccine. 2024, 42:2966-74. 10.1016\/j.vaccine.2024.03.024","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2278362","article-title":"Recombinant zoster vaccine in immunocompetent and immunocompromised adults: a review of clinical studies","volume":"19","author":"Mwakingwe-Omari A","year":"2023","unstructured":"Mwakingwe-Omari A, Lecrenier N, Naficy A, Curran D, Posiuniene I. Recombinant zoster vaccine in immunocompetent and immunocompromised adults: a review of clinical studies. Hum Vaccin Immunother. 2023, 19:2278362. 10.1080\/21645515.2023.2278362","journal-title":"Hum Vaccin Immunother"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66761","article-title":"Factors influencing herpes zoster vaccine utilization among adults aged 50 and above attending primary healthcare center in Saudi Arabia: a cross-sectional study","volume":"16","author":"Almakhdob M","year":"2024","unstructured":"Almakhdob M, Selim M, Abdalrouf A. Factors influencing herpes zoster vaccine utilization among adults aged 50 and above attending primary healthcare center in Saudi Arabia: a cross-sectional study. Cureus. 2024, 16:e66761. 10.7759\/cureus.66761","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/333302-assessing-the-knowledge-attitude-and-practice-of-healthcare-workers-on-the-herpes-zoster-vaccine-in-saudi-arabia-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T06:17:16Z","timestamp":1736662636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/333302-assessing-the-knowledge-attitude-and-practice-of-healthcare-workers-on-the-herpes-zoster-vaccine-in-saudi-arabia-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.77302","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,11]]}}}